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ABSTRACT:  
Reactive astrogliosis is a response to injury in the central nervous system that plays 
essential roles in inflammation and tissue repair. It is characterized by hypertrophy of 
astrocytes, alterations in astrocyte gene expression, and astrocyte proliferation. Reactive 
astrogliosis occurs in multiple neuropathologies, including stroke, traumatic brain injury, 
and Alzheimer’s disease, and it has been proposed as a possible source of the changes in 
diffusion MRI (dMRI) metrics observed with these diseases. In this study, the sensitivity of 
dMRI to reactive astrogliosis is tested in an animal model of focal acute and subacute 
ischemia induced by the vasoconstricting peptide, endothelin-1. Reactive astrogliosis in 
perilesional cortex is quantified histologically by astrocyte surface density as determined 
with a glial fibrillary acidic protein (GFAP) antibody, while perilesional diffusion changes 
were measured in vivo with diffusional kurtosis imaging. We found substantial changes in 
the surface density of GFAP-positive astrocytes and modest changes in dMRI metrics in the 
perilesional motor cortex following stroke. Although there are time-point specific 
correlations between dMRI and histology measures, there is no definitive evidence for a 
causal relationship.   
Keywords: astrogliosis; ischemia; perilesional; stereology; GFAP; diffusion; imaging; MRI 
Abbreviations used: DKI, diffusional kurtosis imaging; dMRI, diffusion MRI; ET-1, 
endothelin-1; FA, fractional anisotropy; GFAP, glial fibrillary acidic protein; IHC, 
immunohistochemistry; MAP2, microtubule-associated protein 2; MD, mean diffusivity; 
MK, mean kurtosis; ROI, region of interest; SMI-312, pan-axonal neurofilament marker; 
TBI, traumatic brain injury. 
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INTRODUCTION 
 Diffusion MRI (dMRI) is commonly applied to investigate changes in brain tissue 
microstructure associated with neuropathologies such as stroke (1), traumatic brain injury 
(TBI) (2), and Alzheimer’s disease (3). Nevertheless, the effects of specific microstructural 
features on diffusion properties measured with dMRI are poorly understood (4,5). In 
response to injury, a key process in brain tissue is reactive astrogliosis, which involves 
hypertrophy of astrocytes, alterations in astrocyte gene expression, and astrocyte 
proliferation (6). Reactive astrogliosis is an essential aspect of neuroinflammation and is 
associated with the preservation of blood brain barrier and tissue repair. As they are among 
the most numerous of glial cells, astrocytes provide important diffusion barriers, making it 
plausible that dMRI could be sensitive to reactive astrogliosis. Indeed, two prior studies of 
white matter injury have found correlations between markers of reactive astrogliosis and 
the axial diffusivity (7,8), while in gray matter associations between reactive astrogliosis 
and the fractional anisotropy (FA) and mean kurtosis (MK) have been observed for TBI 
(9,10). It has also been proposed that reactive astrogliosis may help to account for observed 
alterations in dMRI measures for stroke and Alzheimer’s disease (11,12). However, some 
studies find no links between reactive astrogliosis and dMRI (13,14). 
 Here we examine the connections between dMRI and reactive astrogliosis occurring 
in a rat model of acute to subacute focal ischemia. It is well known that diffusion metrics 
are substantially altered within the core of ischemic lesions (1) and may also change 
significantly in perilesional regions (11,13,15). We utilize diffusional kurtosis imaging 
(DKI) (16-18) to quantify the diffusion properties and astrocyte surface density (19) to 
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quantify reactive astrogliosis. The DKI measurements are made in vivo just prior to 
sacrifice for histology. Astrocytes are visualized using standard immunohistochemistry 
(IHC) procedures and a glial fibrillary acidic protein (GFAP) antibody, a standard marker 
of reactive astrogliosis (20,21), and stereological methods (22) are applied to calculate the 
perilesional astrocyte surface density. Our primary goal is to test the sensitivity of diffusion 
metrics to reactive astrogliosis associated with acute and subacute focal ischemia. 
METHODS 
Animals 
 Long Evans male rats (n=67, 3-4 months old) received food and water ad libitum 
and were kept on a 12:12 hr light:dark cycle. Rats were randomly assigned to one of four 
groups that received endothelin-1 (ET-1) induced strokes and underwent dMRI scans at 
3 hr (n=39), 1 day (n=29), 3 days (n=19), and 7 days (n=10) post-injury. Shortly after these 
scans, a subset of animals were sacrificed for IHC at 3 hr (n=10), 1 day (n=10), 3 days 
(n=9), and 7 days (n=10). Animals that failed to exhibit a lesion at the 3 hr post-injury time 
point were not considered in the data analysis (n=9). For comparison, this study included 
sham animals (n=19) without strokes that also underwent dMRI and were sacrificed for 
histology. All work was done in accordance with the Medical University of South Carolina 
Animal Care and Use Committee guidelines. 
Surgical Procedures  
 Animals were anesthetized with a cocktail of ketamine (110 mg/kg) and xylazine 
(70 mg/kg). Unilateral ischemic lesions were induced via infusion of ET-1 (American 
Peptide, Inc) into layer V of the left forelimb area of the sensorimotor cortex through two 
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holes drilled at 1.0 mm posterior and 2.0 mm anterior and 4.1 mm lateral to bregma (21).  A 
total of 1.2 µl of ET-1 (0.2 µg/µl in sterile saline) was injected into each hole via a 
Hamilton syringe (lowered to -2.5 mm DV), at a rate of 0.6 µl/min. After the final 
application of ET-1, the brain was left undisturbed for 5 min and then the holes were 
covered with gel film and ultraviolet-cured dental acrylic (SDI Limited Inc.). Sham animals 
were anesthetized, received a midline incision and were sutured.  
Diffusion Magnetic Resonance Imaging 
 dMRI scans were acquired at pre-injury and at 3 hr, 1 day, 3 days, and 7 days post-
injury, using a 7T/30 Bruker BioSpec (Billerica, MA) animal scanner. Animals were 
anesthetized with isoflurane/air (4-5% for induction/1-3% for maintenance) for all dMRI 
scans. A standard DKI (18) protocol was utilized consisting of a two-shot spin-echo echo 
planar imaging diffusion sequence with 30 diffusion encoding directions and 5 b-values (0, 
500, 1000, 1500, 2000 s/mm2). Other imaging parameters were: TR/TE = 4750/32.5 ms, 
field of view = 30×30 mm2, matrix = 128×128, in-plane resolution = 0.23×0.23 mm2, slice 
thickness = 1.0 mm, diffusion gradient pulse duration = 5 ms, diffusion time = 18 ms, and 
number of excitations = 2. A total of 19 axial slices with no interslice gap were collected. 
 For quantification of diffusion parameters, the dMRI data was post-processed with 
the Diffusional Kurtosis Estimator (23) software (https://www.nitrc.org/projects/dke/), 
which generated parametric maps of the mean diffusivity (MD), FA, and MK. Directional 
diffusion metrics, such as the axial diffusivity and kurtosis, were not employed, since this 
study focuses on cortical gray matter regions for which the directional metrics provide 
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relatively little additional information beyond that contained in the mean metrics and FA, 
due to the low diffusion anisotropy of gray matter.  
 Regions of interest (ROIs) were drawn manually in the lesion core and perilesional 
motor cortex. All ROIs were inspected for consistency by a single investigator (R.A.W.). 
For the 3 hr, 1 day, and 3 day time points, the lesion core was defined as the distinctly 
hyperintense voxels on the direction-averaged dMRI images with b = 2000 s/mm2. As this 
was often not feasible for animals at 7 days due to tissue degradation, lesion core ROIs 
were not defined at this time point. Nonetheless, perilesional ROIs were defined at 7 days 
so as to be in similar anatomical location as with the earlier time points. The pre-operative 
ROIs were chosen to be similar to the ROIs defined at 3 hr, since all the stroke animals 
were imaged then. All ROIs spanned 3 consecutive slices that encompass the site of injury, 
the primary motor cortex. Examples of ROIs for a single slice in one animal are shown in 
Figure 1. 
Tissue Processing 
 Following MRI scans, subsets of animals at 3 hr, 1 day, 3 days, or 7 days post-
injury were deeply anesthetized with pentobarbital (Euthasol, 100-150mg/kg, IP) and were 
intracardial perfused with 0.1M phosphate-buffer and 4% paraformaldehyde. Six serial 
rostral to caudal sets of 50 µm coronal sections were produced using a vibratome and stored 
in cryoprotectant. Three sets of sections were processed for IHC to ascertain post-injury 
morphological changes in the surface density of astrocytes, dendrites, and axons in the 
perilesional motor cortex.   
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 Briefly, as described previously (11,21), free-floating sections were processed for 
IHC. Tissue was incubated for 48 hr in one of the following primary antibodies: GFAP for 
astrocytes (1:800 rabbit polyclonal; Dako), microtubule protein 2 (MAP2) for dendrites 
(1:500 mouse monoclonal; Sigma-Aldrich), and for axons, pan-axonal neurofilament 
marker (SMI-312; 1:1000 mouse monoclonal; BioLegend). Following primary incubation, 
sections were rinsed and incubated for 2 hr in secondary antibody at a dilution of 1:200 
(horse anti-mouse for MAP2 and SMI-312; goat anti-rabbit for GFAP). Sections were 
incubated in peroxidase-linked avidin-biotin complex (ABC kit) for 2 hr. Immunoreactivity 
was visualized using 3,3′ diaminobenzidine with nickel ammonium sulfate intensification. 
All animals were included in each batch of IHC processing and each batch included 
negative control sections without primary antibody.   
Microstructure Quantification  
 The cycloid grid intersection method (22) was used to determine surface density for 
the GFAP, MAP2 and SMI-312 immuno-reactive processes. For each antibody, we 
sampled tissue that was represented in three adjacent MRI slices that included the forelimb 
area of the sensorimotor cortex. Data were obtained in three adjacent coronal sections 
(~600 µm apart) which included perilesional motor cortex (i.e., between approximately 
+1.2 and -0.26 mm anterior/posterior relative to bregma) (24). Using ImageJ (National 
Institute of Mental Health, Bethesda, MD), cycloid arcs were overlaid on light microscopic 
images, taken at 100× oil immersion (final magnification=1,400×), of four sample regions, 
two adjacent sets (~250 µm) in layers II/III and two sets in layer V beginning at 
approximately 250 µm medial to the lesion core (towards midline), for 3 sections. Each 
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immuno-reactive process that crossed an arc was counted. The surface density was 
calculated using the formula Sv = 2(I/L), where Sv is the surface density, I is the total 
number of intersections and L is the sum of the cycloid arc lengths. Surface densities were 
not obtained for the lesion core as tissue was not viable or our antibodies did not react in 
the core at 72 hr and later.  
Statistical Analysis 
Linear mixed models were used to analyze dMRI metrics with injury group and 
time point, and their interaction as covariates. Normality assumptions were assessed prior 
to running the models and outliers were removed when necessary.  A random intercept was 
used in the model to account for replicates. Post-hoc pairwise comparisons used a Scheffe’s 
adjustment. Analysis of variance (ANOVA) models were used to look for a relationship 
between histology measures by group and injury, as well as their interaction. A significance 
level of 0.05 was used for all other outcomes. Due to a small sample size at each time point, 
when examining dMRI and histology measures Spearman correlations with a corrected p-
value were used. Correlations with a strong correlation coefficient (r>0.7) were deemed 
relevant. Bonferroni adjustments were made for multiple comparisons in the correlations to 
account for the number of time points being compared.  
RESULTS 
 Representative maps of MD, FA, and MK for a single slice from one animal 
scarified at 7 days are shown in Figure 1. Substantial changes within the lesion core are 
apparent for all three metrics, which are consistent with ischemia (Fig. 2A-C). In the lesion 
core, there was a significant time by injury interaction (F149=44.7, p<0.001) and a 
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significant decrease in MD at 3 hours (p<0.001) and 24 hours (p<0.001) compared to sham 
animals and pre-operative levels, which renormalized by day 3 post-injury (Fig. 2A). This 
result is consistent with previous data in the field (1,11,25-27). Additionally, there was also 
a significant time by injury interaction with MK (F156=39.31, p<0.001), and MK remained 
elevated at all time points: 3 hr (p<0.001), 24 hr (p<0.001), and 72 hr (p<0.001) which is 
consistent with previous reports (Fig. 2B; 1,11,25-27). Lastly, there was a significant 
interaction of time by injury in FA (F134=17.83, p<0.001) and FA was significantly reduced 
in the lesion core at 24 hr (p<0.001) and 72 hr (p<0.001) post-injury (Fig. 2C).  
 We examined the same metrics (MD, MK, and FA) in the perilesional motor cortex 
(Fig. 2D-E), which has been less well studied. There was a significant injury by time 
interaction in MD in the perilesional cortex (F133=5.96, p<0.001) and MD was significantly 
decreased at 3 hr (p<0.001) post-injury compared to sham animals and pre-operative levels 
(Fig. 2D). There was not a significant interaction of injury and time in MK, only a 
significant effect of time (F151=4.781, p=0.001). There was a slight increase in MK at 3 hr 
(p=0.016) compared to pre-operative levels (Fig. 2E). There was a significant interaction of 
injury and time (F146=7.222, p<0.001) in perilesional FA which was elevated 3 hr (p<0.001) 
and 24 hr (p=0.006) post-injury compared to pre-operative levels (Fig. 2F). These data 
indicate that not only are dMRI metrics sensitive to differences in the lesion core, but also 
are able to detect changes in the perilesional area of the motor cortex, which undergoes 
ischemia-induced, time-dependent biochemical and structural changes (28). 
  Lastly, we examined the surface density of glia and dendrite processes and axons in 
the perilesional cortex (Fig. 3). It should be noted that by post-injury Day 3, tissue in the 
lesion core is likely not viable and does not reacted to the antibodies used in this study (Fig. 
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3A); thus, we focused on astrocytic (GFAP positive cells) and neural (dendrites and axons) 
structural changes in perilesional cortex and related these to dMRI metrics. There was a 
significant interaction of time and injury (F49=8.03, p<0.001) and significant increases in 
the density of immuno-positive GFAP processes at 3 days (p=0.005) and 7 days (p<0.001) 
post-injury compared to sham animals (Fig. 3B). As seen in Figure 3C, there was a 
significant and strong positive correlation at 24 hr between GFAP positive processes and 
perilesional FA (r=0.85, p=0.001). There was also a strong and significant correlation 
between GFAP-positive processes and perilesional MD on post-injury day 7 (r=0.78, 
p=0.01; Fig. 3D). These data suggest that astrocytes may play a role in the early increase in 
FA levels after stroke and in the return of MD to pre-stroke levels, as previously reported 
(11). However, as discussed in more detail below, these data more strongly suggest that 
dMRI is likely reflecting other morphological and structural changes not measured in this 
study, given that neither FA, MD nor MK changed in synch with the relatively large 
increase in GFAP positive processes that occurred over the hours and days after ischemia.  
There was not a significant interaction of time and injury in perilesional density of 
axon (SMI-312-positive) or dendritic (MAP2-positive) processes (Fig. 4A&B).  However, 
at 24 hr after injury, there was a strong and positive correlation between the density of 
SMI-312-positive axons and perilesional MD (r=0.78, p=0.008; Fig. 4C). Our data suggest 
that changes in axonal and astrocyte density might be involved in some of the changes in 
MD and FA. It is possible that since we examined a fairly large number of comparisons (3 
antibodies X 3 dMRI X 4 time-points = 36) these correlations are statistical anomalies. 
However, given that we only considered r-values over 0.7 to be relevant and corrected for 
multiple-comparisons, these data potentially do reflect real associations between alterations 
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in water diffusion as measured by MD, MK and FA and cellular structure or function 
changes. 
 
DISCUSSION 
 Consistent with prior studies of acute to subacute stroke in animal models 
(11,26,27), we observe that in the core of the lesion tissue MD initially drops following 
ischemic injury and then returns to near normal values by 3 days and that MK markedly 
increases following ischemia and remains elevated out to 3 days. We also observe that 
following ischemic damage the FA value is significantly below the pre-injury and sham 
levels at 1 and 3 days post-stroke. In perilesional cortex, we find a decrease in the MD at 3 
hr and an increase in FA at 3 hr and 24 hr compared to pre-operative levels and sham 
animals. This MD drop is consistent with a similar prior study by our group (11). However, 
this prior study also observed a small but significant increase in the MK at 3 days, whereas 
we did not replicate this in our current study. This may be, in part, due to smaller lesions 
examined by ROI analysis in the present study (482±58 voxels) compared to our early 
report (1188±237 voxels), and thus perilesional cortex MK responses could be less robust 
(11).   
 There was a substantial degree of reactive astrogliosis, as measured by 
GFAP+positive immuno-reactivate processes, in the perilesional cortex at 3 and 7 days 
post-injury, with a more than threefold increase at 7 days in comparison to the baseline 
values from the sham animals. In our prior study (11), a statistically significant correlation 
between the surface density for GFAP and the perilesional MD at 3 days is reported, but 
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this finding is not reproduced here (r=0.09). We do however show a significant correlation 
between GFAP and perilesional MD at 7 days in our current analysis. Again, the later time 
point correlation may be due to the fact that our lesions were smaller in the present study, 
which may have delayed some aspects of the injury response. Astrocyte density correlated 
as well with perilesional FA 24 hr after stroke, but not at any other time points. In other 
models, including traumatic brain injury, GFAP intensity has also been associated with FA 
levels (9).  
 In contrast with the GFAP measurements, the perilesional surface densities for 
dendrites (MAP2) and axons (SMI-312) varied little across the time points, consistent with 
minimal disruption in the structural density of these microstructural components within the 
perilesional cortex. We did detect a significant correlation between axons and perilesional 
FA early after stroke, even though there was a non-significant reduction in axonal processes 
(Fig. 4A&C). FA may be detecting axonal degeneration and axonal demyelination, which 
has been proposed in other models of injury (9). Previous research has shown a link 
between axonal changes and FA in white matter tracts (9,30,31). Further studies are needed 
to determine this possible relationship. 
Astrogliosis is a common feature of CNS injury and disease that produces a variety 
of cellular, molecular, structural and functional changes that, depending on the severity of 
insult, can result in progressive hypertrophy and in severe cases glia scar formation and 
proliferation. As noted by Sofroniew and Vinters (6), GFAP antibodies can be used as a 
sensitive and reliable marker that labels most CNS injury-induced reactive astrogliosis.  
GFAP antibodies also do not necessarily react to all astrocytes in healthy tissue nor does it 
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reveal all the fine distal processes. Further, mild to moderate reactive astrogliosis often 
leads to only negligible astrocyte proliferation (6). Thus, the observed increase in astrocyte 
surface density changes in this study likely does not reflect astrocyte proliferation but 
instead an upregulation of injury-induced GFAP astrocytes undergoing lesion induced 
morphological and functional changes. It is possible that a more severe reactive 
astrogliosis, with astrocyte proliferation and glial scar formation, would be more robustly 
detectable with dMRI. For a rat model of TBI, Zhuo and coworkers (10) found evidence 
linking increased MK with increased GFAP immunoreactivity in gray matter. Similarly, 
Budde and coworkers (9) found that GFAP expression in cortical gray matter had a 
significant positive relationship with FA for TBI. Other studies that have attempted to link 
reactive astrogliosis with diffusion measures report both positive (7,8) and negative results 
(13,14).  
 Our study possesses several limitations that should be taken into consideration when 
interpreting the results. The majority of studies that attempt to find causal links between 
dMRI and histological measures have used correlations between the two, as we have done, 
but as the old adage states―correlations do not determine causality. Future studies would 
benefit from using conditional knockout or knockin animals to help determine the effects of 
altering the expression of different cell types or their structure on dMRI metrics. We 
examined three different cell types using IHC; however many more factors could be 
contributing to changes detected by dMRI. For example, edema, microglia activation, 
inflammation, and cellular apoptosis might also alter dMRI metrics following stroke 
(9,13,32). 
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 One important limitation of this study is that GFAP is not necessarily strongly 
expressed in all astrocytes, and so our measured astrocyte surface densities likely only 
reflect a subset of these cells and should be interpreted accordingly (6). Nonetheless, GFAP 
expression is regarded as a standard marker for reactive astrogliosis (6,20,21), and our 
surface densities may therefore be considered as valid measures of reactive astrogliosis 
severity. Another limitation is possible displacement of the perilesional tissue due to tissue 
degradation within the lesion core over the course of the experiment, which could confound 
the positioning of our perilesional ROIs and contribute to the variability of our 
measurements. For this reason, all ROIs were inspected by a single investigator (R.A.W.) 
for consistency.   
CONCLUSION 
 MD, FA, and MK in the perilesional cortex of focal ischemic injury show minimal 
changes at 1, 3 and 7 days post-injury despite monotonic increase in reactive astrogliosis, to 
over threefold above baseline values at 7 days post-injury. We also found a positive 
correlation between increased GFAP-immunoreactivity in the perilesional gray matter and 
FA acutely (24 h) and MD subacutely (7 days) following focal ischemia. However, the 
dMRI metrics do not correlate across all post-injury time points with GFAP positive 
astrocytes and thus these correlations may indicate a yet unidentified driver of diffusional 
changes of which astrogliosis could be involved or related to, but not necessarily the main 
cause.  
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FIGURE CAPTIONS 
Figure 1: Representative ROIs used for the quantification of diffusion metrics 
superimposed on dMRI images with b = 0 from all time points for one animal (first row).  
An ischemic lesion was induced in the cortex with ET-1. The red ROIs are the lesion core 
and the blue ROIs represent perilesional motor cortex. The lesion core ROIs were manually 
drawn based on the direction-averaged dMRI images with b = 2000 s/mm2 (second row). 
Lesion core ROIs were not defined for the 7 day time point due to difficulty in identifying 
the core. For the pre-injury time point, the lesion core ROI was chosen to be similar to that 
for the 3 hr time point. Parametric maps of the MD (third row) show a drop in the core for 
the 3 hr and 1 day time points, while the FA of the core (fourth row) is low for all post-
injury time points. The MK of the core (fifth row) is, in contrast, elevated following 
ischemia.  
Figure 2: Time courses for MD, FA, and MK in both the lesion core and the perilesional 
cortex. Dashed lines indicate sham levels. In the lesion core we found decreases in MD at 3 
hr and 24 hr post-injury (A.), increases in MK at 3 hr, 24 hr, and 72 hr after injury  (B.), 
and a decrease in FA at 24 hr and 72 hr after stroke (C.). These results are consistent with 
previous reports. In the perilesional cortex we found a decrease in MD at 3 hrs (D.) and an 
increase in FA at 3 hr and 24 hr post-injury (F.). There was not any change in perilesional 
MK following stroke in our model (E.). Perilesional cortex has been examined less post-
injury.  
Figure 3: A. The 7 day b=0 dMRI image with the perilesional ROI compared to a GFAP-
stained section of sampled tissue (scale bar=0.5mm) to compare regions of sampling 
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between dMRI and histology. The sampled region of GFAP is enlarged to a 100x image to 
demonstrate our staining levels (scale bar=50um). Lastly, to illustrate our quantification 
technique we overlaid our cycloid grid arc filter used for counting on an enlarged section of 
GFAP stained tissue (scale bar=50um). B. Immuno-reactive GFAP staining in the 
perilesional cortex and the dashed line indicates sham levels. We observed an increase in 
GFAP at 3 days and 7 days post-injury. C. At 24 hr post-injury, we found a correlation 
between perilesional FA and GFAP, and at 7 days we found a correlation between 
perilesional MD and GFAP (D.).  
Figure 4: A. Levels of immune-reactive SMI-312 in the perilesional cortex revealed no 
differences across time points after stroke. B. There was not a significant difference in 
MAP2 processes over the acute time after stroke, dashed line represents sham animals. 
Lastly, at 24 hr after stroke SMI-312 was significantly correlated with perilesional MD 
(C.).  
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